Cardiac-safety.org

These guidelines have assessed the role of copeptin in the diagnosis of Non ST-segment elevation myocardial infarction (NSTEMI) and made the recommendation “use of copeptin as an additional biomarker for the early rule-out of MI is recommended whenever sensitive or high-sensitivity cardiac troponin assays are not available”. ................
................